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A 52-year-old woman was found to have a lung mass and bilateral breast lesions on
computed tomography (CT). Subsequent positron emission tomography/CT demonstrated
marked uptake in the lung mass and mild uptake within the breast lesions. A diagnostic
mammogram and targeted ultrasound were performed to exclude primary breast malig-
nancy or metastases from presumed pulmonary malignancy. A pertinent history of recent
intravenous drug use with heroin injection into bilateral breasts, together with imaging
features, facilitated diagnosis of fat necrosis. Fat necrosis is a common diagnosis in breast
imaging and may be an incidental finding on positron emission tomography/CT in the
oncologic setting. The presence of fat along with suggestive clinical history can lead to the
diagnosis and appropriate assignment of either benign, breast imaging-reporting and data
system (BI-RADS) 2, or probably benign, BI-RADS 3, category with short interval follow-up.
Appropriate work-up of incidental fluorodeoxyglucose-avid breast masses with diagnostic
mammogram ± ultrasound is warranted to avoid incorrect interpretation as neoplastic
processes.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 52-year-old woman with multiple comorbidities, including
hepatitis C, chronic obstructive pulmonary disease, 100-pack-
year smoking history, remote deep vein thrombosis, and mi-
graines, presented to the emergency department forng regarding this work.
lared that no competing i
ney).
blished by Elsevier Inc. u
ND license (http://creativshortness of breath. Chest radiograph showed a left pulmo-
nary nodule, which prompted a chest computed tomography
(CT) scan that demonstrated a left lower lobe cavitating mass
(images not shown). Fluorodeoxyglucose (FDG) positron
emission tomography (PET)-CT scan demonstrated an FDG-
avid left lower lobe mass and hilar and axillary adenopathynterests exist.
nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
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reactive due to hepatitis C. In addition, on the PET-CT, there
weremultiple irregular soft tissue nodules in bilateral breasts,
which demonstrated mild FDG uptake.
Given the PET-CT scan findings, the patient required
work-up for bilateral breast nodules to evaluate for breast
primary process with subsequent axillary nodal and/or lung
metastasis. Subsequently, she was sent for a bilateral diag-
nostic mammogram including bilateral whole breast images
(Fig. 1) and spot magnification views (Fig. 2). The mammo-
graphic images demonstrate scattered fibroglandular den-
sities (25%-50% fibroglandular), and multiple bilateral breast
masses, which were oval in shape. The 3 largest of these
masses were in the left breast at 1:30-o'clock position, 5 cm
from the nipple, in the left breast at 8:30-o'clock position, 4
cm from the nipple, and in the right breast at 10-o'clock
position, 9 cm from the nipple. The 2 masses in the left
breast demonstrated central low attenuation consistent with
fat density.
The patient then underwent targeted diagnostic ultra-
sound of these 3 masses (Fig. 3). The 2 left breast masses
demonstrated heterogeneous echogenicity consistent with
the presence of fat, indistinct margins, and posterior acousticFig. 1 eWhole breast images from diagnostic
mammogram demonstrate scattered fibroglandular
densities. There are multiple masses in bilateral breasts.
Prior imaging is not available for comparison.shadowing. Targeted ultrasound of the right breast demon-
strated an oval-shaped, hypoechoic solid mass with circum-
scribed margins. During the ultrasound examination, the
patient was queried for any history of trauma to the breast to
potentially support the diagnosis of multifocal fat necrosis.
The patient then endorsed a history of heroin injections into
her bilateral breasts within the past several months.
The 3 sonographic and/or mammographic lesions were
anatomically correlated with the soft tissue nodules demon-
strating mild FDG uptake on recent PET-CT (Fig. 4). The cavi-
tating left lower lobe mass and mediastinal and axillary
lymphadenopathy are again demonstrated on the PET-CT
images (Fig. 5).
Given this history, all the masses were felt consistent
with benign fat necrosis secondary to needle injection. A
breast imaging-reporting and data system (BI-RADS) cate-
gory 3 was assigned to bilateral breasts, with recommen-
dation for short interval follow-up in 6 weeks to document
continued evolution and/or stability of fat necrosis.
Follow-up imaging in 3 months including diagnostic
mammogram and targeted ultrasound of the same 3 sites,
demonstrated continued evolution of the multiple foci of fat
necrosis with stability in size and number of lesions. Repeat
CT scan at this time (not shown) demonstrated increase in
size of the cavitating left lower lobe mass and stability of
mediastinal adenopathy. Mediastinoscopy and left lower
lobectomy were performed, and pathologic evaluation
revealed poorly differentiated nonesmall cell carcinoma with
glandular, squamous, and sarcomatoid differentiation within
the lung and inflammatory and/or reactive adenopathywithin
the mediastinum.Discussion
Fat necrosis of the breast is a benign lesion often encountered
on mammographic, sonographic, and magnetic resonance
imaging (MRI) of the breast [1,2]. The lesion is a sterile in-
flammatory process, most commonly occurring as a response
to localized trauma, such as after blunt (impact to a steering
wheel) and breast intervention, such as biopsy, lumpectomy,
breast flap reconstruction, or radiation [1,2]. The lesion
typically presents as a single or multiple small, painless
lumps [3,4].
The histologic composition of the lesion depends on the
age and will contain varying amounts of degenerating adi-
pocytes and red blood cells, inflammatory cells, and
fibrosis. Early in fat necrosis, degenerating adipocytes and
fresh hemorrhage predominate. In the intermediate phase,
inflammatory histiocytes and multinucleated giant cells
infiltrate, whereas the adipocytes and red blood cells un-
dergo necrosis. In the chronic phase, fibrosis predominates,
possibly enclosing saponified fat, with hemosiderin depo-
sition serving as a nidus for calcifications (yielding
the classic mammographic oil cyst appearance) [1]. On
mammogram, rim, heterogeneous, or dystrophic calcifica-
tions can be seen and usually develop in that order [2]. On
MRI, homogeneous or rim enhancement may be seen [2,4].
Biopsy is warranted when the imaging features are
Fig. 2 e Spot magnification views from the 3 largest bilateral breast masses (top: craniocaudal views and bottom:
mediolateral views). The 3 masses are located in the left breast at 1:30-o'clock (left), left breast at 8:30-o'clock (middle), and
right breast at 10-o'clock (right) positions. They are all oval in shape. The 2 left breast masses contained central lucency
compatible with fat density. The right breast mass could not be confirmed mammographically to be fat containing.
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calcifications are present.
FDG PET-CT is a molecular imaging test used in a wide
variety of oncologic and nononcologic applications. The pri-
mary mechanism for increased FDG uptake is increased
glycolytic activity, as FDG is taken up by the glucose trans-
porter and trapped within the cell. Auxiliary mechanisms for
increased uptake include increased vascularity andcompartmental third spacing. Malignant cells generally have
increased metabolic activity, vascularity, and express an
increased number of glucose transporters, forming the basis
for their visibility on a PET-CT image [5e7].
FDG PET-CT is not currently indicated in the staging of
clinically stage I or II breast cancer, as it has a high false
negative rate for small and/or low-grade primary lesions and
locoregional metastatic lymph nodes. However, it is helpful in
Fig. 3 e Ultrasound images (top: transverse views and bottom: longitudinal views) of 3 breast masses left breast at
1:30-o'clock (left), left breast at 8:30-o'clock (middle), and right breast at 10-o'clock (right) positions. The 2 left breast masses
were heterogeneous in echo texture containing some areas of fat, with irregular margins and posterior acoustic shadowing.
The right breast mass was solid hypoechoic, oval, with circumscribed margins.
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cancer, in troubleshooting situations where standard staging
studies are equivocal, or in evaluation for locoregional recur-
rence [8].
Incidental foci of FDG uptakewithin the breast on a PET-CT
scan are not uncommon. Focal FDG uptake has been described
within many non-neoplastic conditions, including fat necro-
sis, fibroadenomas, silicone granulomata, fibrocystic changes,
postsurgical change, focal inflammation related to ruptured
breast prosthesis, abscess, and even simple breast cysts
[9e14]. Within fat necrosis, mild or even marked uptake may
occur because of the previously mentioned mechanisms,
likely most predominantly due to glycolysis within inflam-
matory white blood cells.Although the appearance of fat necrosis is well docu-
mented on mammography and ultrasound [2], uptake within
fat necrosis is less well recognized [15e18]. Some authors
have described uptake within fat necrosis as a “false posi-
tive” [15,16]; however, we prefer to avoid this description
noting that preferential FDG uptake within fat necrosis
accurately reflects local increased metabolic activity and/or
hyperemia and that FDG PET-CT is not exclusively a test of
malignancy.
Knowledge that fat necrosis and other benign breast
lesions may demonstrate increased FDG uptake is important
to avoid interpreting this finding as malignancy. In general,
correlation of areas of increased FDG uptake with the
appearance on conventional breast imaging modalities will
Fig. 4 e (A) Positron emission tomography (PET)-computed tomography (CT) images (top: fluorodeoxyglucose PET, middle:
noncontrast CT, and bottom: fused CT/PET-CT) demonstrate 3 foci of uptake corresponding with breast masses left breast at
1:30-o'clock (left), left breast at 8:30-o'clock (middle), and right breast at 10-o'clock (right) positions. (B) Magnified CT image of
the lesion in the left breast at 1:30-o'clock demonstrating that it contains fat (HU, ¡37).
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Furthermore, it is often the case that comparison of the degree
of uptake within the breast lesion, with that of the primary
malignancy, as in this case, will allow the radiologist
to confirm that these areas of uptake are because of 2 physi-
ologically distinct processes. For example, the highest
maximum standard uptake value of the breast lesions per-
tained to the left lower inner quadrant lesion, measuring 2.8,
whereas the maxSUV of the left lung lesion was 19.1.
In summary, management of a breast lesion, which
demonstrates mild-to-marked FDG uptake but otherwise hasfeatures of fat necrosis, should not dissuade a radiologist
from this benign diagnosis. Assignment of no follow-up
(BI-RADS 2), short interval follow-up (BI-RADS 3), or recom-
mendation of biopsy (BI-RADS 4) should be determined pri-
marily by the lesion's features on mammography,
ultrasound, and/or MRI images [3]. Clinical history is key in
suggesting this diagnosis. In our patient, although 1 of the 3
lesions did not demonstrate fat, it was otherwise similar in
appearance to these 3 lesions on breast imaging, CT, and
PET. In light of her provided history of bilateral breast in-
jections, this could be comfortably categorized together with
Fig. 5 eWhole body positron emission tomography-computed tomography (CT) maximum intensity projection image (left
andmiddle) demonstrates subtle uptake in mediastinal (green circle) and axillary lymph nodes bilaterally, intense uptake in
left lower lobe cavitating mass (yellow arrow) as demonstrated on axial CT image (right). The foci of mild uptake in the
breasts faintly seen in the left breast (red arrows).
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RADS 3) to confirm the diagnosis.r e f e r e n c e s
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